There is no creatinine number that defines stage 3 kidney disease. Stage 3 is defined by estimated filtration rate, an eGFR between 30 and 59, and the creatinine that produces that eGFR is different for a 45-year-old man and an 80-year-old woman. That said, most people arriving here want a number, so this page gives indicative ranges, explains exactly why they are indicative, and covers what a stage 3 diagnosis actually changes.
The short answer, with the caveat attached. Stage 3 chronic kidney disease means an eGFR of 30 to 59 mL/min/1.73m² sustained for at least three months. In a middle-aged man that usually corresponds to a serum creatinine somewhere between roughly 1.4 and 2.4 mg/dL (about 125 to 215 µmol/L). In an older woman the same stage often sits between roughly 1.0 and 1.8 mg/dL (about 88 to 160 µmol/L). Those are not thresholds. They are the arithmetic consequence of putting different people through the same equation, and they shift with every year of age. Run your own value through the Waldev creatinine clearance calculator rather than comparing yourself to somebody else’s number.
The second thing worth saying early, because it is the thing most people actually want to know. Stage 3 sounds like three-fifths of the way to dialysis. It is not. The stages are descriptive bands on a filtration scale, not stops on a conveyor belt, and the majority of people diagnosed with stage 3 will never reach stage 5 or need dialysis. Many are stable for decades. Some are stable for the rest of their lives, which for a person diagnosed at 78 is a meaningful statement. What changes at stage 3 is not usually your daily life; it is the monitoring around you and the care taken with your medications. If your reading is higher than the ranges above, what high creatinine means and what causes high creatinine levels cover the wider picture.
The Waldev creatinine clearance calculator does the arithmetic for your age, sex and weight, which is the only way a creatinine value becomes a stage. If you want the underlying idea first, what creatinine is and what creatinine clearance means explain it plainly.
On this page
How chronic kidney disease is actually staged
Staging is done on filtration, not on creatinine. The measure is estimated glomerular filtration rate, eGFR, which is a calculated number telling you roughly how many millilitres of blood your kidneys clear per minute, standardised to a body surface area of 1.73 square metres. A healthy young adult sits around 100 to 120. The stages divide that scale into five bands.
Normal filtration. Only counts as kidney disease if there is other evidence of damage, usually protein in the urine or a structural abnormality.
Mildly reduced. Same rule: needs a marker of damage to be called disease. A great many healthy older people sit here.
Mild to moderate reduction. This is where most stage 3 diagnoses are made, and the majority of people here stay here.
Moderate to severe reduction. Monitoring tightens, complications become more likely, and specialist input is more common.
Severely reduced. Nephrology involvement is standard and planning for possible future treatment begins.
Kidney failure. Dialysis or transplantation is considered, though the decision is driven by symptoms and blood chemistry rather than the number alone.
Three details in that scale trip people up. The first is the three-month rule: a single low eGFR is not chronic kidney disease. Chronic means sustained, and the definition requires the abnormality to persist for at least three months. A dehydrated 70-year-old admitted with gastroenteritis can produce an eGFR of 38 on a Tuesday and 71 a fortnight later, and that person does not have stage 3 CKD. They had an acute kidney injury. Being labelled on one reading is a genuine and common error, and if it happened to you, ask for a repeat before accepting the diagnosis.
The second is that stages 1 and 2 are not defined by filtration at all. An eGFR of 95 is normal. It only becomes stage 1 CKD if something else marks damage, most often albumin leaking into the urine. That is why people are sometimes surprised to be told they have stage 1 or 2 disease with a completely normal filtration rate, and it is covered separately in creatinine levels in stage 1 kidney disease.
The third is that stage 3 was split into 3a and 3b in 2012 precisely because the original band was too wide to be useful. An eGFR of 58 and an eGFR of 31 sat in the same category despite carrying substantially different risks. The split is now standard, and if your result letter says stage 3 without a letter after it, that is worth clarifying.
Why no fixed creatinine value defines the stage
Creatinine is a waste product of muscle. Your muscles convert creatine phosphate to creatinine at a fairly steady daily rate, the kidneys clear it, and the concentration left in the blood reflects the balance between those two processes. That second half is the problem. The blood level depends on how much you produce as much as on how well you clear it.
Consider two people with an identical serum creatinine of 1.4 mg/dL. The first is a 35-year-old man who deadlifts four times a week and weighs 98 kg. His muscle mass generates a lot of creatinine, and his kidneys are clearing it at a perfectly normal rate; his eGFR works out around 62 and he does not have kidney disease. The second is a 79-year-old woman weighing 52 kg who has lost muscle steadily over fifteen years. She produces far less creatinine daily, so 1.4 mg/dL represents much poorer clearance; her eGFR is about 36, placing her in stage 3b. Same number on the report. Different diagnosis, different follow-up, different medication doses.
That is the whole reason staging equations exist. The CKD-EPI 2021 equation takes creatinine, age and sex and produces an eGFR, using age and sex as crude proxies for typical muscle mass. Cockcroft-Gault, still used widely for drug dosing, adds actual body weight. Neither measures your muscle; both estimate it from population averages. Where you differ from the average, the estimate is wrong in a predictable direction. The comparison between the two approaches is set out in Cockcroft-Gault versus MDRD, and the broader distinction in creatinine clearance versus GFR.
The practical consequence. If you are very muscular, your eGFR is understated and your true filtration is better than the stage suggests. If you are frail, elderly, amputated or have low muscle mass from chronic illness, your eGFR is overstated and your true filtration is worse than the stage suggests. Neither error is small. In frail older patients the discrepancy can be a full stage.
There is a further wrinkle that matters more than people expect. Creatinine is not only filtered; roughly 10 to 15 percent of it is actively secreted into the urine by transporters in the kidney tubule. Several ordinary medicines block those transporters, including trimethoprim and cimetidine, and they raise measured creatinine by 10 to 20 percent within days without changing filtration at all. Someone started on a course of co-trimoxazole can be pushed from an eGFR of 62 to an eGFR of 52 on paper, be told they have stage 3 CKD, and revert entirely a fortnight after the course ends. This is a real and documented source of false staging, and it is worth telling whoever ordered the test what you were taking that week.
Laboratory variation adds a little more noise. Assays differ, and even a well-run laboratory reports the same sample with a coefficient of variation of a few percent. Combine analytical variation with day-to-day biological variation, hydration status and what you ate the night before, and a creatinine of 1.45 today can read 1.32 next week without anything having changed in your kidneys. Near a stage boundary, that is enough to move you across it. It is one of the strongest arguments for looking at the trend across several results rather than reacting to one.
Indicative creatinine ranges for stage 3, by age and sex
Here is what you came for, with the health warning stapled to it. The table below shows the serum creatinine that produces an eGFR of 59, 45 and 30 for people of different ages and sexes, calculated using the CKD-EPI 2021 equation. The 59 column is where stage 3 begins, the 45 column is the 3a/3b boundary, and the 30 column is where stage 4 begins.
| Age and sex | Stage 3 starts near (eGFR 59) | 3a becomes 3b near (eGFR 45) | Stage 4 starts near (eGFR 30) |
|---|---|---|---|
| Man, 30 | 1.60 mg/dL · 142 µmol/L | 2.00 mg/dL · 177 µmol/L | 2.80 mg/dL · 249 µmol/L |
| Man, 40 | 1.52 mg/dL · 134 µmol/L | 1.91 mg/dL · 168 µmol/L | 2.67 mg/dL · 236 µmol/L |
| Man, 50 | 1.44 mg/dL · 128 µmol/L | 1.81 mg/dL · 160 µmol/L | 2.54 mg/dL · 224 µmol/L |
| Man, 60 | 1.37 mg/dL · 121 µmol/L | 1.72 mg/dL · 152 µmol/L | 2.41 mg/dL · 213 µmol/L |
| Man, 70 | 1.30 mg/dL · 115 µmol/L | 1.63 mg/dL · 144 µmol/L | 2.29 mg/dL · 202 µmol/L |
| Man, 80 | 1.24 mg/dL · 109 µmol/L | 1.55 mg/dL · 137 µmol/L | 2.17 mg/dL · 192 µmol/L |
| Woman, 30 | 1.26 mg/dL · 111 µmol/L | 1.58 mg/dL · 139 µmol/L | 2.21 mg/dL · 195 µmol/L |
| Woman, 40 | 1.19 mg/dL · 106 µmol/L | 1.50 mg/dL · 132 µmol/L | 2.10 mg/dL · 186 µmol/L |
| Woman, 50 | 1.13 mg/dL · 100 µmol/L | 1.42 mg/dL · 126 µmol/L | 1.99 mg/dL · 176 µmol/L |
| Woman, 60 | 1.08 mg/dL · 95 µmol/L | 1.35 mg/dL · 119 µmol/L | 1.89 mg/dL · 167 µmol/L |
| Woman, 70 | 1.02 mg/dL · 90 µmol/L | 1.28 mg/dL · 113 µmol/L | 1.80 mg/dL · 159 µmol/L |
| Woman, 80 | 0.97 mg/dL · 86 µmol/L | 1.22 mg/dL · 108 µmol/L | 1.71 mg/dL · 151 µmol/L |
Read that table as approximate. It assumes a person of average build for their age and sex, an eGFR standardised to average body surface area, and a laboratory using a standardised creatinine assay. It cannot account for your muscle mass, your ethnicity’s effect on typical build, an amputation, a wasting illness, a bodybuilding habit, or a medicine that blocks tubular secretion. Nobody stages a patient from a table like this. It exists to give you a rough sense of scale, and to demonstrate the point that matters: the creatinine marking the start of stage 3 differs by more than 0.6 mg/dL between a 30-year-old man and an 80-year-old woman.
Look at the pattern down the columns. For every ten years of age, the creatinine corresponding to the same eGFR falls by roughly 0.06 to 0.08 mg/dL, because the equation assumes muscle mass declines with age. And at every age, the female value sits roughly 20 to 25 percent below the male value for the same filtration rate. A creatinine of 1.25 mg/dL is unremarkable in a 40-year-old man and marks the start of stage 3b in an 80-year-old woman. If you want the general reference ranges rather than the staging boundaries, what a normal creatinine level is sets those out, and the normal creatinine clearance range covers the filtration side.
If you want to do this properly rather than by lookup, the arithmetic is set out step by step in how to calculate GFR from creatinine, which takes about a minute with a calculator and your last result.
Stage 3a versus stage 3b, and why the split matters
The single band of eGFR 30 to 59 was doing too much work. Risk of progression, cardiovascular risk and rates of complication all rise substantially across it, so lumping an eGFR of 57 with an eGFR of 32 obscured a real difference. The split into 3a and 3b became standard practice with the 2012 KDIGO guideline and is now used almost universally.
Stage 3a · eGFR 45 to 59
Most people here have no symptoms whatsoever and would never have known without a blood test. Complications such as anaemia and disordered bone mineral metabolism are uncommon. In the absence of significant albuminuria, progression is slow or absent in most people, and routine care is usually managed in general practice with blood tests once or twice a year.
Stage 3b · eGFR 30 to 44
Still often symptom-free, but the picture behind the scenes shifts. Anaemia, raised phosphate, secondary hyperparathyroidism and rising potassium become more common and are actively looked for. Testing frequency typically doubles. Drug dose adjustment becomes routine rather than occasional, and referral criteria are met more often.
Put crudely, 3a is mostly a monitoring label and 3b is where kidney disease starts generating work of its own. That distinction is why an annual blood test at 3a often becomes a six-monthly one at 3b, and why a nephrology opinion that was not indicated at an eGFR of 52 may be indicated at 38, particularly if the value is falling or albuminuria is present.
One caution about the boundary itself. Given laboratory variation, an eGFR of 46 and an eGFR of 44 are the same number in any meaningful sense. Do not read a shift from 3a to 3b across a single pair of tests as deterioration. What counts is the direction of travel over years, which is why clinicians plot results rather than compare pairs.
The second axis almost nobody mentions
Staging by eGFR alone is only half the classification, and the missing half is often the more important one. Modern CKD staging is two-dimensional: a G stage from filtration and an A stage from how much albumin is leaking into the urine. Your full label is something like G3a A1 or G3b A3, and the letter after the A changes the outlook considerably more than most people realise.
| Albuminuria category | Urine ACR | Description | What it implies |
|---|---|---|---|
| A1 | Under 3 mg/mmol (under 30 mg/g) | Normal to mildly increased | Low risk of progression. Stable disease is the usual course. |
| A2 | 3 to 30 mg/mmol (30 to 300 mg/g) | Moderately increased | Meaningfully higher risk of decline and of cardiovascular events. Treatment intensity usually rises. |
| A3 | Above 30 mg/mmol (above 300 mg/g) | Severely increased | High risk. Referral thresholds are lower and treatment is more aggressive. |
Here is the comparison that makes the point. A person with an eGFR of 55 and heavy albuminuria at A3 faces a considerably worse outlook than a person with an eGFR of 38 and no albuminuria at A1, even though the second person is a full stage further down the filtration scale. Protein leaking through the filter is both a marker of ongoing damage and a driver of further damage, since the tubules downstream are injured by reabsorbing it. Filtration tells you where you are. Albuminuria tells you where you are going.
The practical implication is straightforward: if you have been told you have stage 3 kidney disease and nobody has tested your urine, that is an incomplete assessment. Ask about an albumin-to-creatinine ratio. It is a single early-morning urine sample and it does more to predict your future than the blood test that generated the diagnosis. The NIDDK guidance on CKD tests and diagnosis is explicit that blood and urine testing belong together. The mechanics of the test are covered in how to calculate an albumin-creatinine ratio.
What stage 3 actually means for your life expectancy and your day
This is the section people scroll for, so it goes here rather than at the end, and it will be honest in both directions.
Start with the reassuring part, because it is the larger part. Most people diagnosed with stage 3 chronic kidney disease do not progress to kidney failure. Kidney function declines slowly in the general population anyway, at roughly 0.5 to 1 mL/min a year after the age of about 40, and a substantial share of stage 3 diagnoses in older adults represent that ordinary decline rather than a disease process going anywhere. Someone diagnosed at 74 with an eGFR of 51, no albuminuria, well-controlled blood pressure and no diabetes is far more likely to die with stage 3 kidney disease than because of it. That is not a grim statement. It is the accurate one, and clinicians say it routinely.
Now the part that deserves weight. Stage 3 is a genuine cardiovascular risk factor, and for most people at this stage the heart is a bigger threat than the kidneys. Reduced filtration is independently associated with higher rates of heart attack, stroke and heart failure, and the association strengthens as eGFR falls and as albuminuria rises. This is why a stage 3 diagnosis usually triggers attention to blood pressure, cholesterol, smoking and diabetes control rather than anything kidney-specific. The single most useful way to think about a stage 3 label is as a flag that your whole cardiovascular risk profile deserves a proper look.
As for daily life, at stage 3a and most of 3b the honest answer is that nothing changes. Symptoms attributable to reduced filtration are unusual above an eGFR of about 30, and where people at this stage do feel tired, it is more often the anaemia, the underlying diabetes, the sleep apnoea or the medication than the kidney function itself. You can work, exercise, travel, drink alcohol in moderation and eat normally. You do not need to give up the gym. You do not need to stop having a glass of wine. Pregnancy is possible and usually successful at this stage with proper planning, though it needs specialist input and is a conversation to have in advance rather than after the fact.
You will probably not feel anything. Fatigue, poor appetite, itch, nausea and swelling are features of stage 4 and 5, not of stage 3. If you have those symptoms at stage 3, they usually have another cause worth finding.
Progression is not inevitable and is often zero. A large proportion of people at stage 3a have a stable eGFR over five and ten years. Stability is a normal outcome, not a lucky one.
Your heart matters more than your kidneys right now. Blood pressure, cholesterol, glucose and smoking do more for your outcome at this stage than anything aimed directly at the kidney.
The number will bounce around. Expect variation of several eGFR points between tests. That is measurement noise, not your kidneys changing week to week.
Age changes the meaning. An eGFR of 48 in a 38-year-old is a different clinical problem from an eGFR of 48 in an 84-year-old, and it will be investigated more thoroughly.
The one group who should take a stage 3 diagnosis more seriously is younger people. A 34-year-old with an eGFR of 47 has four or five decades ahead, and even a slow rate of decline covers a lot of ground over that span. Young patients with stage 3 are generally investigated harder for a specific cause, referred earlier and treated more aggressively, and that is appropriate rather than alarming. For the stages either side, see creatinine levels in stage 4 kidney disease and, for the far end of the scale, what creatinine level indicates kidney failure.
What actually changes when you are diagnosed with stage 3
Six things, roughly, and none of them are dramatic.
Monitoring frequency
The main practical change. At stage 3a with no albuminuria, blood tests are usually annual. At 3a with albuminuria, or at 3b, twice a year is typical, and more often if the trend is downward or something has changed. The tests generally include creatinine and eGFR, electrolytes including potassium, a full blood count to look for anaemia, and a urine ACR. Calcium, phosphate, parathyroid hormone and vitamin D enter the picture at 3b. Nobody is checking these because they expect trouble; they are checking so that trouble is found early, when it is easy to deal with.
Blood pressure targets
Targets tend to be set lower for people with CKD than for the general population, and lower again when albuminuria is present, because blood pressure control is the intervention with the best evidence behind it for slowing decline. Exact targets differ between guidelines and between countries, and they are individualised, so ask what yours is rather than assuming. Home monitoring is often encouraged at this stage. Blood pressure and kidney function feed each other in both directions: raised pressure damages the small vessels supplying the filtering units, and a damaged kidney pushes pressure higher through fluid balance and hormone signalling. Interrupting that loop is the point of the tighter target.
Anaemia checks
The kidney produces erythropoietin, the hormone that tells the bone marrow to make red cells. As function falls, production drops, and anaemia becomes progressively more common through stage 3b and beyond. It is worth finding because it is treatable and because it accounts for a lot of the tiredness people attribute vaguely to their kidneys. A full blood count is standard at review. Iron studies are usually added if haemoglobin is falling, since iron deficiency and kidney-related anaemia frequently coexist.
Bone and mineral checks
Failing kidneys handle phosphate less well and activate vitamin D less efficiently. Phosphate rises, calcium tends to fall, and the parathyroid glands respond by driving up parathyroid hormone, which pulls calcium out of bone. This process starts silently in stage 3, long before anything shows up as a symptom, which is exactly why it is measured at 3b. Left unattended over years it contributes to bone fragility and vascular calcification.
Vaccination
People with reduced kidney function have somewhat impaired immune responses, and infections both hit harder and can knock kidney function down a step. Annual influenza vaccination, pneumococcal vaccination and hepatitis B vaccination are all commonly recommended in CKD, with the specifics varying by country and by individual circumstance. Hepatitis B in particular is given earlier rather than later, because the response is better while kidney function is higher. Ask your own clinician what applies to you.
Referral
Most stage 3 is managed in primary care and never sees a nephrologist, which is appropriate. Referral is generally considered when the eGFR is falling quickly, when albuminuria is heavy, when there is persistent unexplained blood in the urine, when the cause is unclear, when the person is young, when potassium is difficult to control, or when the eGFR drops below about 30. If none of those apply to you and you have not been referred, that is not neglect. It is the system working as designed. The relevant thresholds are set out in the NIDDK overview of chronic kidney disease.
Keeping your own record of creatinine and eGFR over time is genuinely useful, and the Waldev CrCl calculator makes each conversion quick. It sits alongside the rest of the Waldev health calculators.
Medication review and dose adjustment at stage 3
This is where a stage 3 diagnosis has its most immediate practical effect, and it is worth understanding what your prescriber is doing.
Many drugs are cleared by the kidney, either wholly or in part. When filtration falls, those drugs accumulate, and a dose that was correct at an eGFR of 90 can be too high at an eGFR of 40. Metformin, direct oral anticoagulants, gabapentin and pregabalin, several antibiotics, allopurinol, digoxin, many opioids and a long list of others all have kidney-dependent dosing. Below an eGFR of about 45 to 50, dose adjustment starts to matter routinely. This is why your medication list is reviewed after the diagnosis, and why a pharmacist may get involved. The principles are covered in creatinine clearance in drug dosing.
| Category | Examples | Why kidney function matters |
|---|---|---|
| Renally cleared drugs | Metformin, gabapentin, pregabalin, digoxin, allopurinol, some antibiotics | Accumulate as filtration falls; doses are commonly reduced or intervals lengthened |
| Anticoagulants | Apixaban, rivaroxaban, dabigatran, edoxaban | Dosing depends on calculated clearance, usually Cockcroft-Gault rather than eGFR |
| Drugs affecting filtration pressure | ACE inhibitors, ARBs, NSAIDs | ACE inhibitors and ARBs protect the kidney long term despite a small early rise in creatinine; NSAIDs do not |
| Diuretics | Furosemide, thiazides, spironolactone | Effectiveness and safety both change with filtration; potassium needs watching with some |
| Newer protective agents | SGLT2 inhibitors, certain mineralocorticoid receptor antagonists | Produce a small expected dip in eGFR when started, then slow long-term decline |
| Contrast and imaging agents | Iodinated contrast for CT | Risk is lower than once believed but still weighed at stage 3b and below |
Two points there need underlining because they are routinely misunderstood.
First, the expected dip. Several of the medicines that protect kidneys over years cause a small drop in eGFR in the first few weeks, sometimes enough to look alarming on a result letter. That dip reflects a change in pressure across the filter, not damage, and the long-term trajectory on these drugs is better, not worse. Stopping them because the number moved is a well-recognised own goal.
Second, anti-inflammatory painkillers. Ibuprofen, naproxen and diclofenac reduce filtration pressure and, taken regularly at stage 3, are among the more common avoidable contributors to decline. Most people do not think of a supermarket painkiller as medication and do not mention it. Occasional use for a headache is a different proposition from a daily tablet for arthritis, and the second is worth a specific conversation with your doctor about alternatives.
Do not change anything on your own. Nothing on this page is a reason to start, stop, reduce or skip a medicine. Dose adjustment at stage 3 is a prescriber’s decision made with your full medication list, your other conditions and your actual test results in front of them. If you are worried about a particular drug, take the list to your GP or pharmacist and ask. Do not experiment.
One more thing worth asking about: sick day guidance. Some medicines that are helpful day to day become unhelpful when you are vomiting, have diarrhoea or are running a fever, because the kidney is already short of blood flow in those situations. Many people with CKD are given written advice about which tablets to pause temporarily during such an illness and when to restart. If you have stage 3 and have never been given that advice, it is a reasonable and useful thing to request.
What makes progression more likely, and what makes it less
Two people can be diagnosed with an eGFR of 47 on the same morning and be in entirely different positions ten years later. These are the factors that separate them.
| Factor | Direction | Comment |
|---|---|---|
| Albuminuria | Strongly increases risk | The single best predictor available. A3 carries several times the risk of A1 at the same eGFR. |
| Uncontrolled blood pressure | Increases risk | Also the most modifiable factor, which is why it dominates management. |
| Poorly controlled diabetes | Increases risk | The leading cause of CKD worldwide; glycaemic control changes the trajectory. |
| Younger age at diagnosis | Increases lifetime risk | Not because decline is faster, but because there are more years for it to happen in. |
| Male sex | Slightly increases risk | A modest and consistent effect in population studies. |
| Smoking | Increases risk | Affects the small vessels of the kidney as it does everywhere else. |
| Repeated acute kidney injury | Increases risk | Each episode can leave function slightly lower, producing a stepwise decline. |
| Obesity | Increases risk | Partly direct, partly through blood pressure and diabetes. |
| Polycystic kidney disease | Increases risk | An inherited cause with its own, generally faster, trajectory. |
| Regular NSAID use | Increases risk | Common, avoidable, and frequently unmentioned at appointments. |
| Stable eGFR over several years | Reassuring | Past stability is one of the better predictors of future stability. |
| Absent albuminuria | Reassuring | A1 status at stage 3a is close to the low-risk end of the whole classification. |
If you take one thing from that table, take the top row. Albuminuria is the strongest routinely available predictor of whether your kidney function will decline, and it is measurable from a single urine sample. It outperforms the eGFR itself for predicting progression, which is a striking fact given how much attention the eGFR receives and how little the urine test does.
The second thing to take is that the strongest risk factors are also the most modifiable. Blood pressure, glucose control, smoking and weight are not fixed. Neither is regular painkiller use. There is a version of a stage 3 diagnosis in which nothing happens for the next twenty years, and getting there is mostly about ordinary cardiovascular medicine done consistently rather than anything exotic. Practical prevention measures are covered in how to prevent rising creatinine and how to lower creatinine levels.
What a worrying trend actually looks like
A useful rule of thumb: a sustained fall of more than about 5 mL/min per year, or a drop of 25 percent or more from a previous stable baseline, is the sort of trajectory that prompts a closer look. Compare that with the ordinary age-related decline of under 1 mL/min per year and the difference is clear. A person going from 52 to 50 to 49 over three years is stable. A person going from 52 to 44 to 37 is not, and that pattern warrants investigation rather than watchful waiting.
Plotting your results is genuinely worthwhile. A column of numbers in a letter hides a trend that a simple line on paper makes obvious, and it also makes obvious how much random scatter there is, which stops you overreacting to any single value. Bring the plot to your appointment. Clinicians find it useful.
Diet at stage 3, without the misinformation
Diet advice is where people with stage 3 encounter the most nonsense, so this section will be conservative and specific about what is and is not established.
At stage 3, and particularly at 3a, most people do not need a special kidney diet. The restrictions that dominate internet discussion, low potassium, low phosphate, strict protein limits, generally belong to more advanced disease or to people whose blood tests show a specific abnormality. Applying them pre-emptively is not neutral. It narrows the diet, worsens nutrition, and in the case of protein restriction can cause real harm.
Do not restrict protein on your own. This is the single most important dietary warning at stage 3. Unsupervised protein restriction causes muscle loss and malnutrition, both of which independently worsen outcomes, and losing muscle also lowers your creatinine, which makes your eGFR look better while your health gets worse. That is a genuinely dangerous feedback loop. If protein modification is appropriate for you, it should be prescribed and monitored by a renal dietitian, with your weight and nutritional status tracked. Do not attempt it from an article, including this one.
What is reasonably well supported at stage 3 is unglamorous:
Reduce salt. The best-evidenced dietary change at this stage, because it directly supports blood pressure control, which is the intervention that matters most. Most of the salt in a typical diet comes from processed food, bread and eating out rather than the salt cellar, so that is where to look first.
Drink normally to thirst. Forcing large volumes of fluid does not protect kidneys and can cause low sodium, particularly in older people. Unless you have been told otherwise, drink when thirsty and enough to keep urine pale. Dehydration is worth avoiding for the opposite reason, since it reduces blood flow to the kidney and is the most common cause of a temporary creatinine spike.
Eat a mostly plant-based, minimally processed pattern. There is reasonable evidence that dietary patterns high in vegetables, fruit, legumes and whole grains, and lower in processed meat and ultra-processed food, are associated with slower CKD progression. That is a pattern, not a prescription, and it happens to be the same advice given for heart health.
Do not add potassium or phosphate restrictions without a blood test showing you need them. Many potassium-rich foods are also the healthiest things in the shop. Restricting them without cause is a net loss.
Be sceptical of supplements marketed for kidney health. Herbal preparations are not regulated as medicines, some are directly nephrotoxic, and interactions with prescription drugs are common. Tell your doctor about anything you take, including things you would not call medicine.
On creatine supplementation specifically, since it comes up constantly: creatine raises measured creatinine through production rather than through any effect on the kidney, which means it can push a borderline eGFR into stage 3 territory on paper. Whether it is appropriate for someone with established CKD is a question for your own clinician, but the confusion it causes at the lab bench is real, and anyone taking it should say so before a blood test. Creatine and creatinine are different molecules, one a supplement and one a waste product, and conflating them causes a surprising amount of unnecessary investigation.
Your first month after a stage 3 diagnosis
A stage 3 label often arrives by letter or through an app, with no conversation attached, which is why people end up reading pages like this one at eleven at night. Here is a sensible sequence for the four weeks after that.
Check whether the eGFR has been low on at least two occasions three months or more apart. If this is a single reading, the diagnosis is not yet established and a repeat is the correct next step. Ask specifically.
Ask whether a urine ACR has been done and what it showed. If it has not, ask for one. Your full stage is G plus A, and without the A you only have half the information.
Ask for creatinine and eGFR values going back as far as your records allow. The trend over five years is worth more than any single result and will tell you whether this is new or long-standing.
Take everything you take, including over-the-counter painkillers, supplements and herbal products, to your GP or pharmacist. Ask which items need dose adjustment at your filtration rate and which are best avoided.
Ask what your target is and start recording readings at home if advised. This is the lever with the most evidence behind it, and it is largely in your hands day to day.
Diabetes, hypertension, an inherited condition, past obstruction, years of anti-inflammatory use, or simply age. The answer shapes everything that follows, and sometimes nobody has actually asked the question.
Know when your next blood test is and what it will include. Put it in your calendar. Lapsed monitoring is a common and entirely avoidable problem in stage 3.
Two small things that are easy to miss and genuinely useful. Both are standard parts of CKD care and both are frequently overlooked at stage 3.
What not to do in that first month: do not change medication yourself, do not start a restrictive diet, do not buy supplements advertised for kidney repair, and do not read progression statistics from forums and apply them to yourself. Population figures include people with heavy albuminuria, poorly controlled diabetes and rapid decline, and if none of those describe you, neither do the numbers.
Questions worth asking at your next appointment
Ten minutes goes quickly. These are the questions that produce the most useful answers.
About the diagnosis
Is this 3a or 3b? What is my albuminuria category? Has this been confirmed on more than one test at least three months apart? What do you think caused it? Is my eGFR likely to be accurate given my build?
About the trend
What were my previous results? Is my function stable, falling slowly, or falling fast? How much of this is probably ordinary age-related decline? What rate of change would make you concerned?
About treatment
Does any of my medication need its dose changing? Is there anything I take that I should discuss stopping? Should I be on anything specifically to protect my kidneys? What is my blood pressure target?
About the future
How often will I be tested and what will be checked? At what point would you refer me to a nephrologist? What symptoms should prompt me to contact you sooner? Do I need sick day guidance?
If you get one question in, make it the albuminuria one. It changes the risk picture more than anything else you will discuss.
How stage 3 results get misread
Six recurring errors, some made by patients and some made by the system.
Staging from a single blood test. The definition requires three months of persistence. Labelling someone from one result, especially one taken during an illness, a hospital admission or a bout of dehydration, produces diagnoses that vanish on repeat. This is the most common error of all.
Reading stage 3 as three-fifths of the way to dialysis. The bands are not equal steps and progression is not automatic. Stage 3 covers half the total eGFR range in width and contains the large majority of people with CKD, most of whom stay there.
Ignoring the albuminuria axis. A G3a A3 patient and a G3a A1 patient have the same headline stage and materially different futures. Treating them as equivalent is the biggest information loss in routine practice.
Trusting eGFR in someone with unusual body composition. Bodybuilders, amputees, people with muscle-wasting conditions and the very frail all get systematically misestimated. In those cases cystatin C testing, which does not depend on muscle, gives a better answer and is worth asking about.
Missing a drug effect. Trimethoprim, cimetidine and several others raise measured creatinine without touching filtration. A stage assigned during a course of one of these is not a stage.
Panicking over normal scatter. An eGFR of 48 followed by 44 followed by 47 is a stable patient with a noisy test. Reacting to each individual value is exhausting and tells you nothing.
There is a mirror-image error worth naming too: false reassurance in older people with low muscle mass. An 84-year-old woman weighing 46 kg with a creatinine of 1.0 mg/dL looks unremarkable on a report, but that value in that person can represent an eGFR in the low 50s. Age-adjusted equations partly account for this, though not fully in the frailest patients. If a result seems too good for how someone is doing clinically, it probably is. The National Kidney Foundation guide to eGFR covers the limits of the estimate in more detail.
One further nuance concerns the ratio of urea to creatinine, which sometimes appears on the same report. A disproportionately high ratio often points to reduced blood flow to the kidney rather than intrinsic damage, which matters at stage 3 because the first is frequently reversible. If yours has been flagged, what the BUN-creatinine ratio means explains how it is interpreted.
When a stage 3 result needs urgent attention
Stage 3 itself is not an emergency. Certain things happening alongside it are, and they are worth knowing because most of them are treatable if caught quickly.
A sudden, large drop in eGFR. A fall of a quarter or more from your usual value over days or weeks suggests acute injury on top of chronic disease, not ordinary progression. Get it assessed promptly.
Much reduced urine output. Passing markedly less urine than usual, or almost none, needs same-day medical attention.
New swelling or breathlessness. Swelling of the legs, ankles or face, or breathlessness lying flat, can indicate fluid retention and needs urgent review.
Confusion, drowsiness or persistent vomiting. These suggest a significant metabolic disturbance and warrant immediate assessment.
Visible blood in the urine. Always needs investigating, whatever your stage or eGFR.
Severe flank pain or an inability to pass urine. Suggests obstruction, which can damage kidneys quickly and is usually fixable if relieved in time.
Outside those situations, a stage 3 result is something to discuss at a routine appointment rather than something to act on tonight. If you are trying to work out how much concern a particular value deserves, when to worry about creatinine levels works through the thresholds, and what creatinine means in a blood test covers how the result is generated in the first place.
For completeness on where the scale ends: dialysis is not usually considered until eGFR falls well below 15, and even then it is symptoms, potassium, acid-base status and fluid overload that drive the decision rather than a number in isolation. When dialysis is started covers that in detail, and it is a long way from where you are at stage 3.
Stage 1 and stage 4 creatinine levels cover the neighbouring bands, causes of high creatinine covers why the number rose, and how to lower creatinine levels covers what can and cannot be changed. More in the creatinine blog category.
Creatinine and stage 3 kidney disease: frequently asked questions
What is the creatinine level for stage 3 kidney disease?
There is no single value, because stage 3 is defined by an eGFR of 30 to 59 rather than by creatinine. As a rough guide, stage 3 usually corresponds to a creatinine of about 1.4 to 2.4 mg/dL (125 to 215 µmol/L) in a 60-year-old man, and about 1.0 to 1.9 mg/dL (90 to 165 µmol/L) in a 60-year-old woman. The figures shift with age, sex and muscle mass, so the same creatinine can mean stage 2 in one person and stage 3b in another. Only the calculated eGFR gives the stage.
Is stage 3 kidney disease serious?
It is significant but usually not frightening. Most people with stage 3 have no symptoms, never progress to kidney failure and never need dialysis, and in older adults a large share of stage 3 simply reflects normal age-related decline in filtration. What it does mean is a real increase in cardiovascular risk, which is why blood pressure, cholesterol, diabetes control and smoking receive attention after the diagnosis. It also means medication doses need reviewing. Take it as a prompt for careful monitoring rather than as a warning of imminent kidney failure.
What is the difference between stage 3a and stage 3b?
Stage 3a is an eGFR of 45 to 59; stage 3b is 30 to 44. The band was split because risk changes substantially across it and a single category was hiding that. At 3a most people are monitored annually in primary care and complications are uncommon. At 3b testing typically doubles in frequency, anaemia and bone mineral problems are actively looked for, drug dose adjustment becomes routine, and referral to a kidney specialist is more likely. If your letter says stage 3 without a letter, ask which it is.
Can stage 3 kidney disease be reversed?
Scarred filtering units do not regenerate, so genuine chronic damage is not reversed. That said, eGFR can improve in two situations. If part of the drop was caused by something reversible, such as dehydration, a medication effect or an obstruction, treating it can restore function and sometimes moves someone back to stage 2. And if the original diagnosis rested on a single test taken during an illness, a repeat may simply come back normal. Beyond that, the realistic goal at stage 3 is stability, which is achieved far more often than people expect.
What is the life expectancy with stage 3 kidney disease?
For most people it is not meaningfully shortened by the kidney disease itself, particularly at stage 3a without albuminuria and particularly when diagnosed later in life. The main effect on longevity runs through cardiovascular risk rather than through kidney failure, which is why managing blood pressure, cholesterol, glucose and smoking matters so much at this stage. Published survival figures vary enormously depending on age, albuminuria and other conditions, so general statistics are a poor guide to any individual. Your own trend and your albuminuria category tell you far more.
Does stage 3 kidney disease always lead to dialysis?
No, and this is the most common fear worth correcting. The majority of people diagnosed with stage 3 never progress to kidney failure, and many have a stable eGFR for a decade or more. Dialysis is generally considered only when eGFR falls well below 15, which is two full stages away. The people who do progress are usually those with heavy albuminuria, poorly controlled diabetes, uncontrolled blood pressure or an inherited condition. Absent those features, stability is the normal course, not a lucky exception.
What creatinine level in µmol/L means stage 3?
Working in µmol/L, stage 3 begins around 121 µmol/L in a 60-year-old man and around 95 µmol/L in a 60-year-old woman, and stage 4 begins around 213 and 167 µmol/L respectively. Younger people need a higher creatinine to reach the same stage because more muscle means more production; an 80-year-old woman can be in stage 3 at 86 µmol/L. To convert, multiply mg/dL by 88.4. These are approximations from a standard equation, not thresholds, and your own eGFR is the figure that determines the stage.
What should I avoid with stage 3 kidney disease?
Regular anti-inflammatory painkillers such as ibuprofen, naproxen and diclofenac are the clearest thing to discuss with your doctor, since they reduce filtration and are commonly taken without being mentioned. Excess salt works against blood pressure control. Herbal and kidney-health supplements are unregulated and some are directly harmful. Smoking and dehydration both do damage. What you should not do is restrict protein, potassium or phosphate on your own initiative; those changes belong to more advanced disease or specific blood results and need dietitian supervision.
Can stage 3 kidney disease go back to stage 2?
Sometimes, yes. Because eGFR fluctuates and the stage boundaries are arbitrary lines on a continuum, someone at an eGFR of 58 may well read 62 at the next test, and that alone moves them out of stage 3. More substantially, removing a reversible cause such as dehydration, a secretion-blocking antibiotic or an obstruction can produce a genuine improvement. What does not happen is the recovery of filtering units already lost to scarring. Treat a move back to stage 2 as encouraging rather than as proof the disease has gone.
What symptoms does stage 3 kidney disease cause?
Usually none, which is why it is nearly always found on a routine blood test rather than because someone felt unwell. Tiredness, itch, poor appetite, nausea and swelling are features of stage 4 and 5. Where people at stage 3 do feel tired, the cause is more often anaemia, the underlying diabetes, poor sleep or medication than the filtration rate itself, and it is worth investigating rather than attributing to the kidneys. Reduced urine output, new swelling, breathlessness or confusion are not stage 3 symptoms and need prompt medical assessment.
The short version
Stage 3 chronic kidney disease means an eGFR of 30 to 59 sustained over at least three months, split into 3a at 45 to 59 and 3b at 30 to 44. No fixed creatinine defines it, because the same creatinine produces a different eGFR depending on age, sex and muscle mass. Indicatively, stage 3 tends to start near 1.37 mg/dL in a 60-year-old man and near 0.97 mg/dL in an 80-year-old woman. Ask for your albuminuria category as well, because it predicts progression better than the eGFR does.
Most people with stage 3 never reach kidney failure and never need dialysis, and many are stable for decades. What changes is monitoring frequency, medication dose review, blood pressure targets and checks for anaemia and bone mineral problems. Do not restrict protein without supervision. Put your own value in context with the CrCl calculator, and read further in the health blog or across the wider tool library at waldev.com.
Medical disclaimer: This article is general educational information about kidney function tests and CKD staging. It is not medical advice, cannot tell you what stage you are in, and must not be used to decide whether to seek care, delay care, or start, stop or change any medication or diet. The creatinine figures shown are approximations derived from a standard equation and do not apply to every individual. Reference ranges and assays vary between laboratories, and results must be interpreted alongside your history, medications, urine tests and other results. Always discuss your own results with a doctor or qualified healthcare professional, and seek urgent medical attention if you develop much reduced urine output, new swelling, breathlessness, confusion or persistent vomiting.
NIDDK on what chronic kidney disease means, how the stages are defined, and when specialist referral applies. What is chronic kidney disease →
NIDDK on the blood and urine tests used in CKD, and why the albumin-creatinine ratio sits alongside eGFR. CKD tests & diagnosis →
The National Kidney Foundation on eGFR, what the number represents, and the limits of estimating it from creatinine. Estimated GFR explained →